SI-BONE, Inc. (FRA:2K3)

Germany · Delayed Price · Currency is EUR

15.90

-0.10 (-0.62%)

At close: Dec 4, 2025

8.16% (1Y)

Market Cap	715.88M
Revenue (ttm)	164.99M
Net Income (ttm)	-18.54M
Shares Out	n/a
EPS (ttm)	-0.44
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	16.00
Previous Close	16.00
Day's Range	15.90 - 16.00
52-Week Range	10.60 - 17.20
Beta	n/a
RSI	64.22
Earnings Date	Feb 24, 2026

About SI-BONE

SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company offers proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction and degeneration, adult deformity and degeneration, and pelvic trauma, as well as implantable bone products. It also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with a proprietary 3D-printed porous surface and fenestrated ... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies

Founded 2008

Employees 349

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 2K3

Full Company Profile

Financial Performance

In 2024, SI-BONE's revenue was $167.18 million, an increase of 20.37% compared to the previous year's $138.89 million. Losses were -$30.91 million, -28.67% less than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.